Back to Search
Start Over
COVID-19 in patients with lymphoproliferative diseases during the Omicron variant surge.
- Source :
-
Cancer cell [Cancer Cell] 2022 Jun 13; Vol. 40 (6), pp. 578-580. Date of Electronic Publication: 2022 Apr 21. - Publication Year :
- 2022
-
Abstract
- Competing Interests: Declaration of interests Y.H. reports honoraria from Janssen, AbbVie, Roche, Astra-Zeneca, and Medision, not related to this study. I.A. reports speaker’s bureau for Gilead, Novartis, AbbVie, and Janssen and served as a consultant for Janssen, MSD, AbbVie, Novartis, and Roche, not related to this study. The other authors declare no competing interests.
- Subjects :
- Humans
SARS-CoV-2
COVID-19
Subjects
Details
- Language :
- English
- ISSN :
- 1878-3686
- Volume :
- 40
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Cancer cell
- Publication Type :
- Editorial & Opinion
- Accession number :
- 35477028
- Full Text :
- https://doi.org/10.1016/j.ccell.2022.04.015